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Abstract 
Background: Since its invention in the first quarter of the last century, diphtheria toxoid was successfully 
used for vaccination against diphtheria. However, sporadic case and even an epidemic have been 
recorded in many parts of the world, suggesting the presence of genetic factors influencing the immune 
response to this vaccine. 
Aim: To assess the role of three single nucleotide polymorphisms(miRNA-146a G> C, miRNA-
49 T> G and miRNA-196a2 C> T) in miRNA genes in immune response to diph- theria vaccine. 
Subjects and Methods: This study recruited 68 children and adolescents who received three doses 
of diphtheria toxoid. DNA was isolated from the blood lymphocytes and miRNA- 146a,miRNA-149 and 
miRNA-196a2 genes were amplified, and then directly sequenced. Serum levels of anti-diphtheria 
toxoids IgG antibodies were determined by enzyme linked immunosorbent assay, and accordingly the 
immune response was categorized into good, moderate and low immunity .The association of different 
genotypes and alleles with immune status was illustrated statistically. 
Results: Good immune response to diphtheria vaccine was significantly associated with the C allele 
of the polymorphism miRNA-146a G> C. Out of 14 carriers of GG geno- type,11(78.57%)showed 
good immunity compared to only 48.15% of GG carriers who had such immunity (P=0.039).The 
mutant allele of miR-149 T> G was more prevalent than wild type allele G among subjects with good 
immunity .However, the difference was insignificant 
.Genotypes and allele frequencies of the SNP miR-196a2 C> T were very close in different 
immunological statuses. 
Conclusion: The results of the current study suggest the significant role of miRNA-146a G> C gene 
polymorphism and the insignificant role of both miRNA-149 T>G and miRNA- 196a2 C>T gene 
polymorphisms in response to diphtheria toxoids vaccine. More studies are required to find out the 
associations of different polymorphisms in miRNA genes with immune response for different vaccines. 
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1. Introduction 
Diphtheria is a bacterial disease caused by Corynebacterium diphtheria. 
Toxogenic C. diphtheria produces exotoxin which is absorbed by the mucous 
membrane and causes destruction of epithelium with a superficial inflammatory 
response [1]. Before vaccine era, diphtheria was widely spread among children. The 
invention of diphtheria –tetanus- pertussis(DTP) vaccine significantly reduced and 
even eliminated the disease in almost all developed and developing countries. 
However, an epidemic had emerged in the formal Soviet Union at the end of 1980s, 
followed by many cases of the disease in different parts of Europe [2] . This raises the 
question whether the immunity induced by the vaccination regime is sufficient to 
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protect the individual against the disease, or if there are some other factors influence 
this immunity. In fact, individual variation in immune response after vaccination with 
DTP has been observed in many studie [3] [4] [5] . 
MicroRNAs are groups of very short non-coding RNAs which have many 
important physiological and pathological activities [6] [7]. Such activities are mainly 
attributed to post transcriptional modulation exerted by miRNA for multiple gen [8]. 
In respect to im- mune system, specific miRNAs are involved in the regulation of both 
innate and adaptive arms through controlling the development of immune cell 
progenitors and the differentiation and functions of mature cells. Thus, it is not 
surprising to find certain SNPs in miRNA genes having significant influence on the 
immune response and antibody titer to human vac- cines [9][10]. Not only do SNPs 
occur at miRNA genes, but also in pri-miRNA, pre-RNA and mature miRNA 
sequences [11]. Affected miRNA may exert an alteration in expression and/or 
maturation with subsequent influence on immune system, depending on the involved 
miRNA [12]. 
Although a huge number of studies investigated the role of miRNA gene 
polymorphisms in different pathologies, very few studies have addressed the 
association of such polymor- phisms with the response to human vaccines. Thus, this 
study aimed to assess the role  of three polymorphisms in miRNA-146a, miRNA-149 
and miRNA-196a2 in response to diphtheria vaccine among a sample of Iraqi 
children and adolescences. To the best of our knowledge, this is the first published 
study to evaluate the association of immune response to diphtheria vaccine with 
miRNA gene polymorphisms. 
 
2. Subjects  and Methods 
The Study Population 
A total of 68 children and adolescents (age range 8-13 years, 37 male and 31 
female) who were attending Al-Zahraa’ Center for primary health care/ Baghdad during 
the period from November 2015 to April 2016 were recruited for this study. All subjects 
have received three doses of diphtheria-tetanus-pertussis (DTP) vaccine according to the 
center records. 
Blood Samples, DNA Extraction, Gene Amplification and Genotyping from 
each subject, 5 mL of venous blood samples were obtained, 3 mL of which was kept in 
plain tube where the serum was isolated, while 2 mL in EDTA-tube for DNA 
isolation. DNA was isolated from lymphocyte using a ready kit (Favor prep DNA 
extraction mini 
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kit/ Favor Gene Biotechnologies/ Taiwan) following manufacturer’s instructions. 
Three SNPs (rs2910164 in pre-miRNA146a , rs11614913 in pre-miRNA-196a2 and 
rs71428440 in pri-miRNA-149) were selected for this study. These SNPs are 
considered as candidates for miRNAs involved in antigen recognition or immune 
response activation [13]. The primers and PCR conditions are reported elsewhere [14]. 
PCR products were directly sequenced and analyzed by Chromas pro software. 
 
Anti-Diphtheria Antibody Titer 
Immunoglobulin G antibodies for diphtheria toxoids were measured using enzyme 
linked immune-sorbent assay (ELISA, Diphtheria IgG ELISA kit, My Biosource/ 
China) according to manufacturer’s instructions. Briefly, serum samples or standards 
are pipetted into the wells of the microtiter plate.  A binding between the IgG 
antibodies of the serum and   the antigen takes place. After incubation at room 
temperature, the plate was rinsed with washing solution to remove the bound 
material. Anti-human-IgG peroxidase conjugate was added and incubated for 30 
minutes, followed by washing and then addition of TMB solution and incubated for 20 
minutes. Stop solution was added, and the resulted color was measured 
spectrophotometrically at wave length 450 nm. A standard curve was plotted between 
five standard concentrations and their optical density (figure 1). From this curve, the 
concentration of each sample was calculated in relation to its optical density. 
 
Figure 1: Standard curve foranti-diphtheria toxoid IgG antibodies 
 
The result of each sample was assessed according to the manufacturer’s 
instructions as follows: 
<0.01 IU/mL: Low immunity 
0.01 – 0.1 IU/mL: Moderate immunity 
> 0.1 IU/mL: Good immunity 
 
3. Statistical Analysis 
Prism GraphPad software version 4.0 was used for statistical analysis. 
Genotypes and allele frequencies were directly counted and compared 
between each two groups by Pearson Chi square. Continuous variables were 
expressed as mean standard deviation (SD). Differences were considered 
statistically significant at  P<0.05. 
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4. Results 
Antibody Concentration in Different Ages and Genders 
Table 1 shows the immunity against diphtheria vaccine in different ages and 
genders of the study population. Overall, there were no significant differences 
neither between age groups nor between genders. Although age group 8-10 
year had a higher percentage of subjects with better immunity (65.51%) than 
the age group 11-13 years (46.15%), the difference was insignificant 
(P=0.090). Similarly, males showed an insignificantly higher percentage of 
subjects with better immunity (56.77%) than female (51.61%). 
 
Table 1: The immunity against diphtheria vaccine in different ages 
and genders of the study population 
 
 
Association between Different Genotypes and Immunity 
Both miRNA-146a G>C (146 bp)and miRNA-149 T>G (250bp) appeared 
in two geno- types (figures 2 and 3), while miRNA-196a2 C>T (150bp) had 
three genotypes (figure 4). 
Table 3 shows the frequency of different genotypes and alleles of the 
three SNPs in association with different immune response. The 
heterozygous GC genotype of the SNP miRNA-146a G>C is more frequent in 
subjects with better immunity than homozygous GG genotype with significant 
difference (P=0.039). At allele level, the frequency of C allele is significantly 
higher than G allele in those subjects (P=0.049). 
On the other hand, different genotypes and alleles of both miRNA-149 T>G 
and miRNA- 196a2 C>T polymorphisms did not show any significant 
association with immunity to diph- theria toxoids vaccine, although there are 
many variations in the percentage of these geno- types and alleles among 
different levels of immune response (table 3). 
Table 2: Genotypes and allele frequencies of miRNA-146a G>C, miRNA-
149 T>G and miRNA- 196a2 C>T polymorphisms and their associated with 
different levels of immune response to diphtheria toxoids vaccine 
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Figure 2: Different genotypesof the SNP rs2910164 (miRNA-146a G>C).A: Homozygous wild type GG, B: 
heterozygous genotype CG. 
 
 
 
Figure 3: Different genotypesof the SNP rs71428440 (miRNA-149 T>G).A: Homozygous wild type TT, B: 
heterozygous genotype GT. 
 
 
 
Figure 4:  Different genotypesof the SNP rs11614913 (miRNA-196a2C>T). A: Homozygous wild type CC,  
B: heterozygous genotype CT, C: homozygousmutant genotype TT 
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Table 2: Genotypes and allele frequencies of miRNA-146a G>C, miRNA-149 
T>G and miRNA- 196a2 C>T polymorphisms and their associated with different 
levels of immune response to diphtheria toxoids vaccine 
 
 
 
 
5. Discussion 
he only SNP which was found to have significant association with antibody 
response to diphtheria vaccine was miRNA-146a G>C (rs2910164). This result is in 
accordance with that obtained by Xiong et al. [15] who found significant effect of 
this SNP on the humoral immune response to hepatitis B vaccine in Chinese 
population. Furthermore, the current result agrees with many previous studies in that 
the SNP miRNA-146a G>C has a significant effect on the innate and adaptive immune 
response. For example, [16] showed a significant association of this polymorphism 
with the susceptibility to severe sepsis in the Chinese population, while [17] 
recorded similar association with the susceptibility to leprosy among Brazilians. 
Among the many significant roles of miRNA-146a is its role as a negative regulator 
of the immune response [18] . There is almost a general agreement that miRNA-146a 
acts mainly on two adaptor molecules which are Interleukin-1 receptor-associated 
kinase 1(IRAK-1) and Tumor Necrosis Factor Receptor-Associated Factor 6 
(TRAF6) through 3 prime un- translated region (3’UTR) causing down-regulation of 
expression of these molecules [19]. 
As these molecules are very important as signaling molecules to activate both 
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innate and adaptive immune response, high levels of miRNA-146a exert a negative 
regulatory effect on the immune system. Many experimental studies supported this role. 
Researches on miRNA- 146a-deficient animals revealed an increase in both IRAK1 
and TRAF6 accompanied by an increase in the percentage of IFN-γ producing T-cell 
subset. Moreover, decreased levels of miRNA-146a have resulted in increased 
number, but an impaired function of T-regulatory cells (Treg) with massive 
lymphocyte activation [20] [16]. 
Polymorphisms in miRNA genes were found to have a great influence on 
biogenesis and maturation as well as on the gain or loss of function of miRNA [21]. 
The SNP rs2910164 is located in the stem region of pre-miRNA-146a and the 
presence of mutant allele (allele C) affects the integrity of the stem loop and the 
processing of precursor miR-146a to mature one [22]. Practically, C allele was found 
to be associated with a decrease the mature miRNA- 146a production and unmasking 
the expression of both TRAF6 and IRAK-1 [23] [24] . Thus, robust immune response 
is expected with the presence of this allele and that explains the association of this 
polymorphism with several autoimmune diseases [25]. 
The immune response to diphtheria toxoids is of humoral type represented by IgG 
an- tibodies. The current results imply that C allele carrier has higher IgG titer than 
those carrying G allele. As mentioned above, C allele associates with increased gene 
expression of both IRAK-1 and TRAF6. Although these two adaptor molecules are 
primarily influenced innate immune response through toll-like receptors (TLRs), there 
are strong evidences that they have significant roles in antibody production [26] 
showed that TRAF6 is essential for B cell development and function. Among the most 
important findings of those authors is that signaling of TRAF6 was very important for 
the generation and maintenance of B cell pool. Furthermore, TRAF6 was necessary 
for CD40 function in B cell during T-cell dependent humoral immune response. 
Although less prominent, IRAK-1 also indirectly influence antibody production 
through TLRs carried on B cells. Upon ligand engagement, the transmemebrane 
and cytoplasmic interleukin receptor (TIR) domain of TLR interact with myeloid 
differentiation protein 88 (MyD88). This interaction recruits IRAK-4 which 
stimulates the phosphorylation of IRAK- 1, a step that is necessary for recruitment 
and activation of TRAF6 [27] . 
Contrary to miRNA-146a G>C, both miRNA-149 C>T and miRNA-196a2 T>G 
showed no association with humoral immune response to diphtheria toxoids vaccine. 
Despite some evidence for the role of miRNA-149 as a negative regulator for TLR-
induced inflammatory response [28] , its role in adaptive immunity is not well 
documented, and the SNP miRNA- 149 was reported frequently to have no relevance 
with immune respons [15] [29] . 
MiR-196a2 C>T has been reported to have a role in the pathogenesis of different 
patholo- gies such as colon-rectal cancer [30] and inflammatory bowel disease [31] . 
However, a large number of studies suggested a null association with many other 
diseases especially those related to immune response. [15] did not find any 
significant effect of this SNP in immune response to hepatitis B vaccine. Almost 
similar result was obtained by [29] in studying pul- monary tuberculosis in Chinese 
population. More recently, [32] reported a null association of this polymorphism with 
asthma phenotype, disease duration, and age of onset in Egyptian population. 
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These data strongly suggested the role of miRNA-146a G>C in the humoral 
response to diphtheria toxoid vaccine, although more studies with larger sample size 
are required for the more solid conclusion. 
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 ةصلاخلا 
 مت نا ذنم دقف كلذ عمو قانخلا ضرم دض حيقلتلا يف حاجنب لوتقملا ايرتفدلا نافيذ مدختسا يضاملا نرقلا نم لولاا عبرلا يف هعارتخا
 اذهل ةيعانملا ةباجتسلاا ىلع رثوت ةيثارو لماوع دوجو ىلا ريشي ام نم ملاعلا نم ةديدع ءازجا يف ةئبوا ىتحو لب ةيدرف تلااح تلجس
ا ةساردلا تفده .حاقللا( ةينيج تارياغت ثلاث رود مييقت ىلا ةيلاحلmiRNA-146aG>C  ، miRNA-149T>G ،(miRNA-
1962aC>T نيج يف MicroRNA  ةساردلا هذه تمدختسا .ايرتفدلا حاقل دض ةيعانملا ةباجتسلاا يف68  اوقلت نمم اقهارمو لافط
نيج ةفعاضمو ايلاخ نم لزع مت . ايرتفدلا حاقل نم عرج ثلاث MicroRNAلا ءارجا مث نمو ، ةبولطملا ةينيجلا تارياغتلل رظانم
 تفنص كلذ ءوض ىلعو يميزنلاا يعانملا صاصمدلاا ةقيرطب ةداضملا ماسجلال ةيلصملا تايوتسملا تددح . دعاوقلا عباتت رابتخا
خملا تلايللااو ةينيجلا طامنلاا ةقلاع ديدحت متو ، ةضفخنم وا ةطسوتم , ةديج ىلا ةيعانملا ةباجتسلاا مادختساب ةعانملا ىوتسمب ةفلت
 ليللااب ايونعم ايرتفدلا حاقل دض ةديجلا ةعانملا تطبترا . ةيئاصحلاا قئارطلاC  ينيجلا رياغتللMicroRNA  نيب نمو ,14  ادرف
ينيجلا طمنلا نولمحيCG  رهظا11 ((%78.57  ةنراقم ةديج ةيعانم ةباجتسا ب%48.15  ينيجلا طمنلا نولمحي امم طقفGG 
(P=0.039(رفاطلا ليللاا ناكو )G ينيجلا رياغتلل )miRNA-149T>G ليللاا نم اراشتا رثكاT    ينيجلا ةعانملا يوذ دارفلاا نيب
. ةفلتخملا ةيعانملا تلااحلا يف ادج ابراقتم ناك دقف رياغتلل تلايللااو ةينيجلا طامنلاا عيزوت اما . ايونعم نكي مل قرفلا نا لاا 
ساردلا جئاتن ريشت نيج رياغتل مهم رود ىلإ ةيلاحلا ة miRNA-146aG>C  نيج تارياغت نم لاكل مهم ريغ رودو miRNA-149 
T>G  وmiRNA-196a2 C>T فدلا حاقلل ةيعانملا ةباجتسلاا يفث ةقلاع نع فشكلل تاساردلا نم ديزملا ءارجإ بجيو , اير
تانيج يف ةفلتخملا ةينيجلا تارياغتلا MicroRNA  ةباجتسلاا عم .ةفلتخملا تاحاقلل ةيعانملا 
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